Osteoporosis International

, Volume 24, Issue 2, pp 595–603 | Cite as

Discriminating sarcopenia in community-dwelling older women with high frequency of overweight/obesity: the São Paulo Ageing & Health Study (SPAH)

  • D. S. Domiciano
  • C. P. Figueiredo
  • J. B. Lopes
  • V. F. Caparbo
  • L. Takayama
  • P. R. Menezes
  • E. Bonfa
  • R. M. R. PereiraEmail author
Original Article



The criteria most used for the definition of sarcopenia, those based on the ratio between the appendicular skeletal muscle mass (ASM) and the square of the height (h2) underestimate prevalence in overweight/obese people whereas another criteria consider ASM adjusted for total fat mass. We have shown that ASM adjusted for fat seems to be more appropriate for sarcopenia diagnosis.


Since the prevalence of overweight and obesity is a growing public health issue, the aim of this study was to evaluate the prevalence and risk factors associated with sarcopenia, based on these two criteria, among older women.


Six hundred eleven community-dwelling women were evaluated by specific questionnaire including clinical data. Body composition and bone mineral density were evaluated by dual X-ray absorptiometry. Logistic regression models were used to identify factors independently related to sarcopenia by ASM/h2 and ASM adjusted for total fat mass criteria.


The prevalence of overweight/obesity was high (74.3 %). The frequency of sarcopenia was lower using the criteria of ASM/h2 (3.7 %) than ASM adjusted for fat (19.9 %) (P < 0.0001). We also note that less than 5 %(1/23) of sarcopenic women, according to ASM/h2, had overweight/obesity, whereas 60 % (74/122) of sarcopenic women by ASM adjusted for fat had this complication. Using ASM/h2, the associated factors observed in regression models were femoral neck T-score (OR = 1.90; 95 % CI 1.06–3.41; P = 0.03) and current alcohol intake (OR = 4.13, 95 % CI 1.18–14.45, P = 0.03). In contrast, we have identified that creatinine (OR = 0.21; 95 % CI 0.07–0.63; P = 0.005) and the White race (OR = 1.81; 95 % CI 1.15–2.84; P = 0.01) showed a significant association with sarcopenia using ASM adjusted for fat.


In women with overweight/obesity, ASM adjusted for fat seems to be the more appropriate criteria for sarcopenia diagnosis. This finding has relevant public health implications, considering the high prevalence of overweight/obesity in older women.


Appendicular muscle mass Fat mass Obesity Prevalence Sarcopenia Women 



This work was supported by grants from the Fundação de Amparo e Pesquisa do Estado de São Paulo (FAPESP) #03/09313-0 and #04/12694-8, Conselho Nacional de Ciência e Tecnologia #300559/2009-7 (RMRP), Federico Foundation (EB, RMRP) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (JBL, CPF).

Conflicts of interest



  1. 1.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, European Working Group on Sarcopenia in Older People et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423PubMedCrossRefGoogle Scholar
  2. 2.
    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763PubMedCrossRefGoogle Scholar
  3. 3.
    Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889–896PubMedCrossRefGoogle Scholar
  4. 4.
    Zoico E, Di Francesco V, Guralnik JM, Mazzali G, Bortolani A, Guariento S et al (2004) Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 28:234–241PubMedGoogle Scholar
  5. 5.
    Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Health ABC Study Investigators et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51:1602–1609PubMedCrossRefGoogle Scholar
  6. 6.
    Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd (2005) Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60:213–216PubMedCrossRefGoogle Scholar
  7. 7.
    Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W et al (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 33:885–892CrossRefGoogle Scholar
  8. 8.
    Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E (2003) Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med 25:226–231PubMedCrossRefGoogle Scholar
  9. 9.
    Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, Health, Ageing and Body Composition Study et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with ageing in older men and women. J Am Geriatr Soc 55:769–774PubMedCrossRefGoogle Scholar
  10. 10.
    Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727PubMedCrossRefGoogle Scholar
  11. 11.
    Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemics of obesity in the United States. JAMA 286:1195–1200PubMedCrossRefGoogle Scholar
  12. 12.
    Deurenberg P, Yap M (1999) The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13:1–11PubMedCrossRefGoogle Scholar
  13. 13.
    Gutiérrez-Fisac JL, López E, Banegas JR, Graciani A, Rodríguez-Artalejo F (2004) Prevalence of overweight and obesity in elderly people in Spain. Obes Res 12:710–715PubMedCrossRefGoogle Scholar
  14. 14.
    Gigante DP, Moura EC, Sardinha LM (2009) Prevalence of overweight and obesity and associated factors, Brazil, 2006. Rev Saude Publica 43(Suppl 2):83–89PubMedCrossRefGoogle Scholar
  15. 15.
    Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Menezes PR, Scazufca M et al (2011) Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporos Int 22:711–719PubMedCrossRefGoogle Scholar
  16. 16.
    Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med 115:837–842PubMedGoogle Scholar
  17. 17.
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRefGoogle Scholar
  18. 18.
    Schwartz AV, Villa ML, Prill M, Kelsey JA, Galinus JA, Delay RR et al (1999) Falls in older Mexican-American women. J Am Geriatr Soc 47:1371–1378PubMedGoogle Scholar
  19. 19.
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRefGoogle Scholar
  20. 20.
    Fitti JE, Kovar M (1987) The supplement on ageing to the 1984 national health interview survey. Vital Health Stat 1:1–115Google Scholar
  21. 21.
    Angbratt M, Möller M (1999) Questionnaire about calcium intake: can we trust the answers? Osteoporos Int 9:220–225PubMedCrossRefGoogle Scholar
  22. 22.
    Fuchs SC, Guimarães SM, Sortica C, Wainberg F, Dias KO, Ughini M et al (2002) Reliability of race assessment based on the Osteoporos Int race of the ascendants: a cross-sectional study. BMC Public Health 2:1–5PubMedCrossRefGoogle Scholar
  23. 23.
    World Health Organisation (1998) Obesity: preventing and managing the global epidemic. World Health Organisation, Geneva, Technical Report Series, 894Google Scholar
  24. 24.
    Lipschitz DA (1994) Screening for nutritional status in the elderly. Prim Care 21:55–67PubMedGoogle Scholar
  25. 25.
    Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRefGoogle Scholar
  26. 26.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930PubMedCrossRefGoogle Scholar
  27. 27.
    Shepherd JA, Lu Y, Wilson K, Fuerst T, Genant H, Hangartner TN et al (2006) Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom 9:31–36PubMedCrossRefGoogle Scholar
  28. 28.
    Iannuzzi-Sucich M, Prestwood KM, Kenny AM (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 57:M772–M777PubMedCrossRefGoogle Scholar
  29. 29.
    Walsh MC, Hunter GR, Livingstone MB (2006) Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 17:61–67PubMedCrossRefGoogle Scholar
  30. 30.
    Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A et al (2012) Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 67(1):48–55PubMedCrossRefGoogle Scholar
  31. 31.
    Tieland M, Borgonjen-Van den Berg KJ, van Loon LJ, de Groot LC (2012) Dietary protein intake in community-dwelling, frail, and institutionalised elderly people: scope for improvement. Eur J Nutr 51(2):173–179PubMedCrossRefGoogle Scholar
  32. 32.
    de Deco CP, do Santos JF, da Cunha Vde P, Marchini L (2007) General health of elderly institutionalised and community-dwelling Brazilians. Gerodontology 24:136–142PubMedCrossRefGoogle Scholar
  33. 33.
    Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S et al (2010) A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 110:57–65PubMedCrossRefGoogle Scholar
  34. 34.
    Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W et al (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity study (KSOS). Diabetes Care 33:1497–1499PubMedCrossRefGoogle Scholar
  35. 35.
    Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ et al (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Ageing (KLoSHA). Diabetes Care 33:1652–1654PubMedCrossRefGoogle Scholar
  36. 36.
    Sternfeld B, Ngo L, Satariano WA, Tager IB (2002) Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol 156:110–121PubMedCrossRefGoogle Scholar
  37. 37.
    Villareal DT, Banks M, Siener C, Sinacore DR, Klein S (2004) Physical frailty and body composition in obese elderly men and women. Obes Res 12:913–920PubMedCrossRefGoogle Scholar
  38. 38.
    Baumgartner RN (2000) Body composition in healthy ageing. Ann N Y Acad Sci 904:437–448PubMedCrossRefGoogle Scholar
  39. 39.
    Heymsfield SB, Wang Z, Baumgartner RN, Ross R (1997) Human body composition: advances in models and methods. Annu Rev Nutr 17:527–558PubMedCrossRefGoogle Scholar
  40. 40.
    Stephen WC, Janssen I (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Ageing 13:460–466CrossRefGoogle Scholar
  41. 41.
    Gale CR, Martyn CN, Cooper C, Sayer AA (2007) Grip strength, body composition, and mortality. Int J Epidemiol 36:228–235PubMedCrossRefGoogle Scholar
  42. 42.
    Bunout D, de la Maza MP, Barrera G, Leiva L, Hirsch S (2011) Association between sarcopenia and mortality in healthy older people. Australas J Ageing 30:89–92PubMedCrossRefGoogle Scholar
  43. 43.
    Tilg H, Moschen A (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature 6:772–783Google Scholar
  44. 44.
    Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C et al (2006) Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 84:1193–1199PubMedGoogle Scholar
  45. 45.
    Instituto Brasileiro de Geografia e Estatística 2011. Censo 2010: Brazil Available at, Accessed 20 March 2011.
  46. 46.
    Scazufca M, Menezes PR, Araya R, Di Rienzo VD, Almeida OP, Gunnell D, Sao Paulo Ageing & Health Study et al (2008) Risk factors across the life course and dementia in a Brazilian population: results from the Sao Paulo Ageing & Health Study (SPAH). Int J Epidemiol 37:879–890PubMedGoogle Scholar
  47. 47.
    Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Scazufca M, Bonfá E et al (2009) Vitamin D insufficiency: a risk factor to vertebral fractures in community-dwelling elderly women. Maturitas 64:218–222PubMedCrossRefGoogle Scholar
  48. 48.
    De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRefGoogle Scholar
  49. 49.
    Ho-Pham LT, Nguyen ND, Lai TQ, Nguyen TV (2010) Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women. BMC Musculoskelet Disord 11:59PubMedCrossRefGoogle Scholar
  50. 50.
    Blazer DG, Wu LT (2011) The epidemiology of alcohol use disorders and subthreshold dependence in a middle-aged and elderly community sample. Am J Geriatr Psychiatry 19:685–694PubMedCrossRefGoogle Scholar
  51. 51.
    Martín-González C, González-Reimers E, Santolaria-Fernández F, Fernández-Rodríguez C, García-Valdecasas-Campelo E, González Díaz A et al (2011) Prognostic value of changes in lean and fat mass in alcoholics. Clin Nutr 30(6):822–830PubMedCrossRefGoogle Scholar
  52. 52.
    Hosten AO (1990) BUN and Creatinine. In: Walker HK, Hall WD, Hurst JW (eds) Clinical methods: the history, physical, and laboratory examinations, 3rd edn. Butterworths, Boston, Chapter 193Google Scholar
  53. 53.
    Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107–1213PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2012

Authors and Affiliations

  • D. S. Domiciano
    • 1
  • C. P. Figueiredo
    • 1
  • J. B. Lopes
    • 1
  • V. F. Caparbo
    • 1
  • L. Takayama
    • 1
  • P. R. Menezes
    • 2
  • E. Bonfa
    • 1
  • R. M. R. Pereira
    • 1
    Email author
  1. 1.Bone Metabolism Laboratory, Rheumatology DivisionFaculdade de Medicina da Universidade de São PauloSão PauloBrazil
  2. 2.Department of Preventive MedicineFaculdade de Medicina da Universidade de São PauloSão PauloBrazil

Personalised recommendations